XTL Biopharmaceuticals Ltd ADR (XTLB) — Cash Flow Quality Index
XTL Biopharmaceuticals Ltd ADR (XTLB) has a Cash Flow Quality Index of 0.04x as of December 2021. Operating cash flow of $79.00K is below net income of $2.10 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore XTLB strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
XTL Biopharmaceuticals Ltd ADR Cash Flow Quality Index (2009–2021)
Historical Cash Flow Quality Index for XTL Biopharmaceuticals Ltd ADR across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check XTL Biopharmaceuticals Ltd ADR (XTLB) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for XTL Biopharmaceuticals Ltd ADR (2009–2021)
Year-by-year earnings quality comparison for XTL Biopharmaceuticals Ltd ADR. For live market cap and the full company financial profile, see market value of XTL Biopharmaceuticals Ltd ADR.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | -2.41x | $-1.05 Million | $435.00K | ▼ -782.4% |
| 2018 | -0.27x | $-816.00K | $2.99 Million | ▲ +71.6% |
| 2009 | -0.96x | $-2.49 Million | $2.59 Million | — |